Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
(2023) Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis Hudson, Jemma, et al
Value Pack Overview Primary Research Focus: Selective molecular binding and metabolic pathway modulation Form: Synthetic research compounds Included Compounds: S4 (Andarine) + GW-501516 (Cardarine) Bundle Type: Dual-compound research stack Typical Research Duration: Protocol-dependent Hormonal Classification: Non-steroidal research compounds Common Research Contexts: Metabolic efficiency models, pathway selectivity studies, endurance-related signaling research Copy Brawn20 for 20% off Combines two well-studied research compounds with distinct but complementary molecular mechanisms Allows researchers to examine both selective receptor binding (S4) and metabolic pathway modulation (GW-501516) within a single experimental framework Non-steroidal research compounds frequently referenced in controlled laboratory and analytical studies Intended strictly for laboratory research use only
Researchers often explore MOTS-c in conjunction with other mitochondrial-targeting peptides like SS-31 (Elamipretide)
Monitoring: Depending on the peptide and its intended use, your healthcare provider may recommend regular monitoring of certain health parameters, such as hormone levels or blood markers
The price of the starting dose of 0.8 mg is $149/month, the 2.5 mg dose is $199/month, the 5.5 mg and 9 mg dose is $299/month and the 14.5 mg and 17.2 mg doses is $349 per month, or $299 per month if you refill within 45 days
US$ 21.82
US$ 21.94
US$ 28.32
US$ 23.01
US$ 20.38
US$ 29.87
US$ 20.74
